Home/Specialties/Substance use disorder treatment
Revenue management for substance use disorder treatmentYour Claim Is Not Just a Bill. It Is a Disclosure. Does Your Consent Cover It?
Every other specialty can put a claim in the post without thinking about what the claim reveals. Substance use disorder treatment cannot. Federal law restricts the use and disclosure of any record that would identify a patient as having or having had a substance use disorder, and a claim sent to a payer is exactly such a record. So in this field the revenue cycle begins with a consent document, and a revoked consent is a revenue event.
Start with the free CareVixis practice assessment. No email required.
A Claim Says Something About Your Patient.
It names the programme, the patient and the service. Together those identify someone as having a substance use disorder.
Federal law restricts exactly that.
So Consent Comes Before Billing.
A single written consent covering treatment, payment and health care operations makes routine billing workable.
Without one that covers payers, the claim is not simply late. It cannot go.
And Consent Can Be Withdrawn.
It runs until the patient revokes it in writing.
That is their right, and it is also a moment when a programme needs to know precisely what is outstanding.
Your Billing Partner Is Downstream of It.
Whoever bills for you receives records identifying patients as having a substance use disorder.
That is a disclosure decision, not only a procurement one.
Which Is Why We Say It First.
CareVixis is one of those downstream parties, and a partner who treats that as a footnote has not understood the field.
Your clinical system stays exactly where it is.
Everywhere else, billing is paperwork. Here it is a disclosure.
The detail, if you want it
What 42 CFR Part 2 says about records, consent and downstream recipients, where treatment programmes lose money, and the questions worth putting to any billing partner in this field.
Does 42 CFR Part 2 affect billing for substance use disorder treatment?
Yes, directly. The restrictions apply to records that would identify a patient as having or having had a substance use disorder, whether directly, by reference to publicly available information, or through verification by another person. A claim naming the program, the patient and the service is such a record.
The regulation provides a workable route. Where a patient gives a single written consent for all future uses and disclosures for treatment, payment and health care operations, a Part 2 program, covered entity or business associate may use and disclose those records for those purposes as permitted by the HIPAA regulations, until the patient revokes that consent in writing. That is what makes routine billing possible. It is also why the consent document, not the claim, is the thing to get right.
What the Regulation Actually Says
['These are quotations from 42 CFR Part 2 itself, cited below. This page is not legal advice and CareVixis does not give any; it sets out what the published rule says so a programme can ask its own counsel the right questions.', 'The detail that matters most to a revenue cycle is in the consent requirements: the regulation supplies language for describing recipients, and it includes third-party payers explicitly.']
| Where it bites | What the published rule says |
|---|---|
| What is protected | The restrictions apply to records that “would identify a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person”. |
| The route to routine billing | Where consent is “a single consent for all future uses and disclosures for treatment, payment, and health care operations”, a Part 2 programme, covered entity or business associate may use and disclose those records for those purposes as permitted by the HIPAA regulations. |
| Until when | That permission runs “until such time as the patient revokes such consent in writing”. |
| Naming the recipients | A written consent must include the names or classes of persons to which a disclosure is to be made. For a single consent covering treatment, payment and health care operations, the recipient may be described as “my treating providers, health plans, third-party payers, and people helping to operate this program” or a similar statement. |
| Other required elements | The consent must include the name of the patient, the identification of the person authorised to make the disclosure, and a description of the information “that identifies the information in a specific and meaningful fashion”. |
| Downstream handling | Where records are disclosed for payment or health care operations to a lawful holder that is not a covered entity or business associate, that recipient may further disclose them as necessary for its contractors, subcontractors or legal representatives to carry out payment or health care operations. |
| Paper or electronic | The regulation states that a written consent may be paper or electronic. |
CareVixis states the regulation as it is written and does not interpret it. A programme should take its own legal advice; the point of this page is that the revenue cycle and the confidentiality regime are the same problem here, not two problems.
A Billing Partner Is Downstream of Your Consent
In most specialties choosing a billing company is an operational decision. In substance use disorder treatment it is also a disclosure decision, because the partner receives records that identify patients as having a substance use disorder.
The regulation anticipates this. It addresses what a recipient may do with records disclosed for payment, including what is necessary for contractors, subcontractors or legal representatives to carry out payment activities. But it means the consent document and the vendor relationship have to be consistent with each other, and a programme should be able to explain how they are.
CareVixis is one of those downstream parties. Treating that as a footnote would be the wrong way to win the work. It is the first thing a programme should ask about, and any partner that has not thought about it is telling you something.
What ordinary billing assumes
- The claim can be sent.
- The payer can be called about it.
- The balance can be pursued.
- A vendor can hold the record.
What Part 2 makes conditional
- Whether a valid consent covers the disclosure.
- Which recipients the consent names.
- What happens when consent is revoked in writing.
- What a downstream holder may do next.
Where a Substance Use Disorder Programme Loses Money
Not every programme sees all of these. They are what CareVixis expects to look at first, and several are compliance questions before they are revenue questions.
Consent that does not name payers
The regulation supplies language describing recipients including third-party payers. A consent that omits the class the claim is going to has not authorised the disclosure the claim makes.
Revocation with claims in flight
Consent runs until revoked in writing. Revocation is a clinical and ethical event first, and it is also a point at which a programme needs to know exactly what is outstanding and what may still be done.
Consent expiring against a long episode
Treatment episodes here can run for months. A consent framework designed around a single admission does not always survive the length of the care.
Levels of care and their documentation
Programmes commonly move patients between intensities of service. Each level has its own authorisation and medical necessity expectations, and transitions are where documentation most often lags.
Authorisation for continued stay
Where a payer requires concurrent review, the revenue depends on clinical information reaching a reviewer on time. A day of care delivered without an authorisation in place is rarely recoverable later.
Balances nobody may chase
Ordinary collections activity is a disclosure too. A programme needs to know what its consent permits before it decides how to pursue a balance.
CareVixis publishes no denial rate, recovery rate or resolution time for substance use disorder treatment or any other specialty, and does not suggest any programme experiences all of this. This page is not legal advice.
Where This Fits Around What You Already Run
Where a substance use disorder claim goes, and where CareVixis joins it. The consent step is first for a reason.
- ConsentA written consent meeting the regulation's requirements, naming or describing the recipients, including third-party payers.
- Admission and level of careThe level of service and the documentation supporting it are what a payer's review will examine.
- Authorisation and concurrent reviewWhere continued stay requires review, clinical information has to reach the reviewer while the care is being delivered.
- Claim, which is also a disclosureSubmitted under the consent that authorises it.
- VixisIQ™CareVixis revenue intelligence reads the resulting remittance information, where appropriate data can be obtained and normalized, and looks at authorisation and denial patterns across episodes rather than claim by claim.
- VixisTrace™Where a claim was denied, rejected or underpaid, CareVixis claim root cause analysis works eight stages: Detect, Investigate, Identify, Correct, Prevent, Resubmit, Verify, Monitor.
- The CareVixis teamPeople handle the appeal, the review call and the aged balance, within what the consent permits. Denials are worked the day they arrive; submitting the corrected claim or appeal the same day is the CareVixis standard.
What to Ask Any Billing Partner in This Field
Ask CareVixis all of them. The first three are not ordinary procurement questions, and a partner who has no answer to them has not worked in this field.
-
How do you handle Part 2 records?
Ask directly, and ask what happens to records already held when a patient revokes consent in writing.
-
Does our consent cover disclosure to you?
Ask them to point at the language. The regulation describes recipients including third-party payers and people helping to operate the programme.
-
What do your subcontractors see?
The regulation addresses further disclosure by a recipient for payment activities. Ask who else touches the record.
-
Who chases a balance, and how?
Collections activity discloses the relationship. Ask what their process does and does not do here.
-
How do you handle concurrent review?
Revenue for continued stay depends on information reaching a reviewer on time. Ask who owns that clock.
-
Do you understand levels of care?
Ask them to describe the transitions your programme uses and what documentation each one needs.
-
What happens to a denied day of care?
Ask whether it is appealed, and on what evidence, or quietly written off.
-
Do you handle credentialing?
Programme and practitioner enrollment gaps produce denials that look like authorisation problems.
-
Where is your team?
Ask where the people handling these records sit. CareVixis is 100% US based and does not outsource.
Using Substance use disorder treatment? Keep It.
Keep the clinical record system your programme already uses. CareVixis manages the revenue cycle around it and does not require a software change to begin.
Keeping your system is a supported outcome, not a fallback. If a programme later wants to move to the CareVixis platform, that move may be offered at no additional migration charge, and everything the patient sees still carries the programme's own name and branding.
Keep your systems. Get the consent and the claim to agree with each other.
Questions Treatment Programmes Ask
Is a claim a disclosure under 42 CFR Part 2?
The regulation restricts use and disclosure of records that would identify a patient as having or having had a substance use disorder, directly or by reference to publicly available information or verification by another person. A claim identifying the programme, the patient and the service falls within that description, which is why consent governs whether it can be submitted.
Can a programme bill routinely under Part 2?
Yes. Where a patient gives a single written consent for all future uses and disclosures for treatment, payment and health care operations, the records may be used and disclosed for those purposes as permitted by the HIPAA regulations, until the patient revokes that consent in writing.
What must a written consent contain?
Among other elements, the patient's name, identification of who is authorised to make the disclosure, a description of the information that identifies it in a specific and meaningful fashion, and the names or classes of recipients. The regulation offers wording describing recipients as treating providers, health plans, third-party payers and people helping to operate the programme.
Does CareVixis give legal advice on Part 2?
No. CareVixis states what the published regulation says and works within it. A programme should take its own legal advice on how Part 2 applies to its consents, its vendors and its collections practices.
Can CareVixis work aged balances for a programme?
Yes, within what the consent permits. Legacy accounts receivable is a separate arrangement charged on what is actually recovered rather than on the balance handed over. Terms are on the pricing page.
What is VixisIQ™?
VixisIQ™ is the CareVixis revenue intelligence technology. It analyses revenue cycle and remittance data to surface payment patterns, adjustments, denial and rejection patterns, payer behaviour and accounts receivable trends. What it can analyse for a particular practice depends on the data that practice is able to make available.
What is VixisTrace™?
VixisTrace™ is the CareVixis claim root cause analysis technology, covering rejected, denied, underpaid and otherwise problematic claims across eight stages. The objective is continuous improvement: identify preventable patterns, address their causes, and reduce unnecessary repeat failures.
Does CareVixis work with behavioral health practices generally?
Yes. CareVixis publishes a separate cluster for mental and behavioral health covering billing, credentialing, technology, communications and growth. See mental and behavioral health revenue management.
Keep Substance use disorder treatment. Add Revenue Intelligence.
In this field the consent document and the revenue cycle are the same subject. A partner who treats them as separate has not understood the work.
Free. No obligation. No email required.
Sources
- Electronic Code of Federal Regulations, 42 CFR § 2.12 Applicability. Source of the statement that the restrictions on use and disclosure apply to records which would identify a patient as having or having had a substance use disorder either directly, by reference to publicly available information, or through verification of such identification by another person. ecfr.gov. Accessed 21 September 2026.
- Electronic Code of Federal Regulations, 42 CFR § 2.33 Uses and disclosures permitted with written consent. Source of the statement that a single consent for all future uses and disclosures for treatment, payment and health care operations permits use and disclosure for those purposes as permitted by the HIPAA regulations until the patient revokes consent in writing, and of the provision for further disclosure by a lawful holder as necessary for contractors, subcontractors or legal representatives to carry out payment or health care operations. ecfr.gov. Accessed 21 September 2026.
- Electronic Code of Federal Regulations, 42 CFR § 2.31 Consent requirements. Source of the required elements of a written consent, of the statement that consent may be paper or electronic, and of the suggested wording describing recipients as “my treating providers, health plans, third-party payers, and people helping to operate this program” for a single consent covering treatment, payment and health care operations. ecfr.gov. Accessed 21 September 2026.
42 CFR Part 2 is amended from time to time and the eCFR pages cited carry the current text. Nothing on this page is legal advice.
The CareVixis Model, Applied to Billing for Substance Use Disorder Treatment
The six CareVixis pillars stay consistent (Revenue Cycle, Credentialing, Technology, Communications, Operations and Growth) while the workflow adapts to this specialty's documentation, coding, payer and operational requirements. Keep the systems that work for you; CareVixis connects responsibility around them.